Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Change in Receivables (2023 - 2025)

Historic Change in Receivables for Metagenomi (MGX) over the last 3 years, with Q3 2025 value amounting to $87000.0.

  • Metagenomi's Change in Receivables rose 10821.53% to $87000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $371000.0, marking a year-over-year increase of 11112.44%. This contributed to the annual value of -$1.2 million for FY2024, which is 14871.48% down from last year.
  • Per Metagenomi's latest filing, its Change in Receivables stood at $87000.0 for Q3 2025, which was up 10821.53% from -$139000.0 recorded in Q2 2025.
  • Metagenomi's 5-year Change in Receivables high stood at $1.6 million for Q3 2023, and its period low was -$1.5 million during Q4 2023.
  • In the last 3 years, Metagenomi's Change in Receivables had a median value of -$245000.0 in 2025 and averaged -$152000.0.
  • Examining YoY changes over the last 5 years, Metagenomi's Change in Receivables showed a top increase of 14534.96% in 2024 and a maximum decrease of 16635.34% in 2024.
  • Quarter analysis of 3 years shows Metagenomi's Change in Receivables stood at -$1.5 million in 2023, then skyrocketed by 145.35% to $668000.0 in 2024, then plummeted by 86.98% to $87000.0 in 2025.
  • Its last three reported values are $87000.0 in Q3 2025, -$139000.0 for Q2 2025, and -$245000.0 during Q1 2025.